CureVac Tshuag nyuam qhuav tau kho dua tshiab. Tam sim no nws yog tus neeg sib tw hauv mRNA Tshuaj Tiv Thaiv.



CureVac


tau npaj txhij los sib tw hauv cov pab koomtes loj nrog nws cov tshuaj tiv thaiv, raws li tus kws tshuaj ntsuam UBS uas hais tias cov khoom lag luam nce siab muaj chaw ntau dua.

UBS tus kws tshuaj ntsuam Eliana Merle tau hloov kho cov shares (ticker: CVAC) mus Yuav los ntawm Neutral thiab tsa nws lub hom phiaj 12 lub hlis rau cov nqi khoom lag luam rau $ 18 los ntawm $ 8 rau hnub Thursday. Merle tau teev cov ntaub ntawv kho mob tsis ntev los no thiab lub tuam txhab biopharmaceutical muaj peev xwm tau txais kev sib koom ua lag luam raws li qhov laj thawj rau kev txhim kho.

Tau qhov twg los: https://www.barrons.com/articles/curevac-stock-mrna-moderna-upgrade-51674159571?siteid=yhoof2&yptr=yahoo